Jiang Y, Alam JJ, Gomperts SN, Maruff P, Lemstra AW, Germann UA, et al. Preclinical and randomized clinical evaluation of the p38alpha kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration. Nat Commun. 2022;13(1):5308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alam J, Maruff P, Doctrow SR, Chu H-M, Conway J, Gomperts SN, et al. Association of plasma phosphorylated tau with the response to neflamapimod treatment in patients with dementia with Lewy bodies. Neurology. 2023. https://doi.org/10.1212/WNL.0000000000207755. Published online ahead of print.

Jiang Y, Rigoglioso A, Peterhoff CM, Pawlik M, Sato Y, Bleiwas C, et al. Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF. Neurobiol Aging. 2016;39:90–8.

Article  CAS  PubMed  Google Scholar 

Jarzebowski P, Tang CS, Paulsen O, Hay YA. Impaired spatial learning and suppression of sharp wave ripples by cholinergic activation at the goal location. Elife. 2021;10.

Spencer B, Desplats PA, Overk CR, Valera-Martin E, Rissman RA, Wu C, et al. Reducing endogenous alpha-synuclein mitigates the degeneration of selective neuronal populations in an alzheimer’s disease transgenic mouse model. J Neurosci. 2016;36(30):7971–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mandler M, Rockenstein E, Overk C, Mante M, Florio J, Adame A, et al. Effects of single and combined immunotherapy approach targeting amyloid beta protein and alpha-synuclein in a dementia with Lewy bodies-like model. Alzheimers Dement. 2019;15(9):1133–48.

Article  PubMed  PubMed Central  Google Scholar 

Lin S, Leitao ADG, Fang S, Gu Y, Barber S, Gilliard-Telefoni R, et al. Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy. Neurobiol Dis. 2023;178: 106010.

Article  CAS  PubMed  Google Scholar 

Teipel SJ, Fritz HC, Grothe MJ. Alzheimer’s Disease Neuroimaging I. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease. Neurology. 2020;95(10):e1301–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandez-Cabello S, Kronbichler M, Van Dijk KRA, Goodman JA, Spreng RN, Schmitz TW, et al. Basal forebrain volume reliably predicts the cortical spread of Alzheimer’s degeneration. Brain. 2020;143(3):993–1009.

Article  PubMed  PubMed Central  Google Scholar 

Kantarci K, Nedelska Z, Chen Q, Senjem ML, Schwarz CG, Gunter JL, et al. Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration. Brain Commun. 2022;4(2):fcac013.

Article  PubMed  PubMed Central  Google Scholar